nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of hairy cell leukemia with markedly hypocellular marrow mimicking aplastic anemia
|
Salib, Christian |
|
|
137 |
1 |
p. 142 |
artikel |
2 |
Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation
|
Abrams, Simon T. |
|
|
137 |
1 |
p. 103-114 |
artikel |
3 |
Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulants
|
Ansell, Jack |
|
|
137 |
1 |
p. 115-125 |
artikel |
4 |
Ciraparantag: the next anticoagulant airbag?
|
Siegal, Deborah M. |
|
|
137 |
1 |
p. 10-11 |
artikel |
5 |
Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era
|
Bobillo, Sabela |
|
|
137 |
1 |
p. 39-48 |
artikel |
6 |
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma
|
Goicoechea, Ibai |
|
|
137 |
1 |
p. 49-60 |
artikel |
7 |
Expression of Nras Q61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice
|
Wen, Zhi |
|
|
137 |
1 |
p. 61-74 |
artikel |
8 |
From the inside: GVHD and glucose metabolism
|
Stelljes, M. |
|
|
137 |
1 |
p. 11-12 |
artikel |
9 |
Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI
|
Assmann, Julian C. |
|
|
137 |
1 |
p. 126-137 |
artikel |
10 |
Kindlin-3: at the right place at the right time
|
Margraf, Andreas |
|
|
137 |
1 |
p. 1-2 |
artikel |
11 |
Kindlin-3 recruitment to the plasma membrane precedes high-affinity β2-integrin and neutrophil arrest from rolling
|
Wen, Lai |
|
|
137 |
1 |
p. 29-38 |
artikel |
12 |
p53 activation during ribosome biogenesis regulates normal erythroid differentiation
|
Le Goff, Salomé |
|
|
137 |
1 |
p. 89-102 |
artikel |
13 |
Reduced-intensity therapy for pediatric lymphoblastic leukemia: impact of residual disease early in remission induction
|
Sidhom, Iman |
|
|
137 |
1 |
p. 20-28 |
artikel |
14 |
Risk factors in multiple myeloma: is it time for a revision?
|
Corre, Jill |
|
|
137 |
1 |
p. 16-19 |
artikel |
15 |
Stage I DLBCL: extranodal may mean extra radiation
|
Lossos, Izidore S. |
|
|
137 |
1 |
p. 3-5 |
artikel |
16 |
Superenhancing AML with Trib1
|
Keeshan, Karen |
|
|
137 |
1 |
p. 8-9 |
artikel |
17 |
The winding road toward the myeloma mouse
|
Tonon, Giovanni |
|
|
137 |
1 |
p. 7-8 |
artikel |
18 |
Thrombopoietin receptor agonists as an emergency treatment for severe newly diagnosed immune thrombocytopenia in children
|
Nolla, Marie |
|
|
137 |
1 |
p. 138-141 |
artikel |
19 |
Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9
|
Yoshino, Seiko |
|
|
137 |
1 |
p. 75-88 |
artikel |
20 |
Undetectable MRD can change the deal
|
Corre, Jill |
|
|
137 |
1 |
p. 5-6 |
artikel |
21 |
When non-Whiteness becomes a condition
|
Merz, Lauren E. |
|
|
137 |
1 |
p. 13-15 |
artikel |